| http://www.w3.org/ns/prov#value | - A disease-modifying drug would revolutionize the treatment of this debilitating disease.TNF alpha is a cytokine and a key player in inflammation, and has been identified as a major contributor to pain (signs and symptoms) and cartilage degeneration (structure modification), the main clinical characteristics of OA. Current treatments for OA comprise mainly of non-steroidal anti-inflammatory drugs
|
